1. "Oxford University Press"
  2. "Thomas Kaley"
Formats
  1. Meeting Abstract (46)
  2. Journal Article (8)
  3. Guidelines (1)
  4. Review (1)
Groups
  1. Tow Center for Developmental Oncology (TCDO) (22)
  2. GSK Faculty (18)
  3. Radiology, Department of (18)
  4. Human Oncology and Pathogenesis Program (17)
  5. Neuroradiology Service (17)
  6. Biostatistics Service (11)

More Groups

People
  1. Thomas Kaley (56)
  2. Lisa De Angelis (18)
  3. Antonio Omuro (16)
  4. Ingo Mellinghoff (16)
  5. Igor Gavrilovic (15)
  6. Craig Nolan (14)

More People

Years
  1. 2023 (3)
  2. 2022 (2)
  3. 2021 (3)
  4. 2020 (4)
  5. 2019 (2)
  6. 2018 (6)

More Years

Publications
  1. Neuro-Oncology (54)
  2. Annals of Oncology (1)
  3. Neuro-Oncology Practice (1)
Publishers
  1. Oxford University Press (56)

Results (56)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: A phase 1/2 trial
    Meeting Abstract

    Nassiri, F.; Patil, V.; Yefet, L.; Singh, O.; Liu, J.; Dang, R.; Yamaguchi, T.; Daras, M.; Cloughesy, T.; Colman, H.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Application of the GBM-X data platform to estimate treatment effects of the experimental therapies of the randomized phase 2 individualized screening trial of innovative glioblastoma therapies
    Meeting Abstract

    Rahman, R.; Trippa, L.; Fell, G.; Lee, E.; Arrillaga-Romany, I.; Touat, M.; Drappatz, J.; Welch, M.; Galanis, E.; Ahluwalia, M.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Results of safety lead in of phase IL trial of combination olaparib, temozolomide, and pembrolizumab for patients with IDH-mutant glioma
    Meeting Abstract

    Fortunato, J.; Newton, A.; Gonzalez, A.; Gavrilovic, I.; Miller, A.; Grommes, C.; Lin, A.; Pentsova, E.; Mellinghoff, I.; Kaley, T.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Focused ultrasound mediated blood-brain barrier penetrance to enable cell-free DNA (cfDNA) as a liquid biopsy in recurrent primary brain tumors
    Meeting Abstract

    Miller, A.; Ramamurthy, B.; Pike, L.; Keralapura, M.; Hofius, J.; Marshall, J.; Jones, M.; Lee, C. Y.; Stember, J.; Brennan, C.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • EANO - EURACAN - SNO Guidelines on circumscribed astrocytic gliomas, glioneuronal, and neuronal tumors
    Guidelines

    Rudà, R.; Capper, D.; Waldman, A. D.; Pallud, J.; Minniti, G.; Kaley, T. J.; Bouffet, E.; Tabatabai, G.; Aronica, E.; Jakola, A. S.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • The CDK4/6 inhibitor abemaciclib in patients with recurrent meningioma and other primary CNS tumors
    Meeting Abstract

    Coffee, E.; Panageas, K.; Young, R.; Morrison, T.; Daher, A.; Grommes, C.; Gavrilovic, I. T.; Lin, A.; Miller, A.; Schaff, L.; more...
    Neuro-Oncology (2021)

    Fulltext@MSK | Save
  • Evaluating feasibility and efficiency of phase II adaptive platform trial designs based on the individualized screening trial of innovative glioblastoma therapy (INSIGhT)) experience
    Meeting Abstract

    Rahman, R.; Trippa, L.; Lee, E. Q.; Arrillaga-Romany, I.; Touat, M.; Fell, G.; McCluskey, C.; Bruno, J.; Gaffey, S.; Drappatz, J.; more...
    Neuro-Oncology (2021)

    Fulltext@MSK | Save
  • Preliminary results of the neratinib arm in the individualized screening trial of innovative glioblastoma therapy (INSIGhT): A phase II platform trial using bayesian adaptive randomization
    Meeting Abstract

    Arrillaga-Romany, I.; Trippa, L.; Fell, G.; Lee, E. Q.; Rahman, R.; Touat, M.; McCluskey, C.; Bruno, J.; Gaffey, S.; Drappatz, J.; more...
    Neuro-Oncology (2021)

    Fulltext@MSK | Save
  • Neurologic assessment in neuro-oncology (NANO) scale in a phase II study of pembrolizumab or pembrolizumab plus bevacizumab in patients with recurrent glioblastoma
    Meeting Abstract

    Nayak, L.; Molinaro, A.; Peters, K.; Clarke, J.; Jordan, J.; de Groot, J.; Nghiemphu, P.; Kaley, T.; Colman, H.; McCluskey, C.; more...
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • Preliminary results of the abemaciclib arm in the individualized screening trial of innovative glioblastoma therapy (INSIGhT): A phase II platform trial using Bayesian adaptive randomization
    Meeting Abstract

    Wen, P.; Trippa, L.; Lee, E.; Fell, G.; Rahman, R.; Arrillaga-Romany, I.; Touat, M.; McCluskey, C.; Brunno, J.; Gaffey, S.; more...
    Neuro-Oncology (2020)

    Fulltext@MSK | Save